USPSTF 2020 Recommendations on Screening for Asymptomatic Bacterial Vaginosis in Pregnancy
- 7 April 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (13), 1253-1255
- https://doi.org/10.1001/jama.2019.22311
Abstract
Bacterial vaginosis during pregnancy is associated with higher risks of pregnancy complications, including preterm birth, whether or not symptoms are reported. Bacterial vaginosis is currently considered to be a microbial imbalance of the lower genital tract characterized by low levels of “healthy” Lactobacillus and overgrowth of a mixed population of other bacterial genera, including Gardnerella, Atopobium, Prevotella, Mobiluncus, Sneathia, and other taxa. Many of these microbes are also common isolates from sites of intrauterine infection, including the placenta and amniotic fluid. These findings have motivated investigators to conduct clinical trials to examine the potential benefits and harms associated with screening and treatment of asymptomatic bacterial vaginosis in pregnant women, either applied to a general obstetric population or targeting women at increased risk for preterm delivery, such as those with prior preterm birth. This is particularly important in light of growing concerns about the effects of antibiotic use on long-term maternal and child health because of effects on their microbiomes.This publication has 21 references indexed in Scilit:
- Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trialThe Lancet, 2018
- Molecular Diagnosis of Bacterial Vaginosis: an UpdateJournal of Clinical Microbiology, 2018
- Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US womenProceedings of the National Academy of Sciences of the United States of America, 2017
- Validation of Self-reported Maternal and Infant Health Indicators in the Pregnancy Risk Assessment Monitoring SystemMaternal and Child Health Journal, 2014
- Antibiotics for treating bacterial vaginosis in pregnancyEmergencias, 2013
- Equality in Obstetrical Care: Racial/Ethnic Variation in Group B Streptococcus ScreeningMaternal and Child Health Journal, 2010
- Evidence on the Benefits and Harms of Screening and Treating Pregnant Women Who Are Asymptomatic for Bacterial Vaginosis: An Update Review for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2008
- Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled studyBMC Women's Health, 2008
- Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysisAmerican Journal of Obstetrics and Gynecology, 2003
- A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in NeonatesThe New England Journal of Medicine, 2002